The Global Wearable Healthcare Devices Market Size was Valued at USD 39.9 Billion in 2023 and the Worldwide Wearable Healthcare…
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Grund zur Freude haben Anleger, die in das Wertpapier von Dexcom investiert haben: Der Kurs des Wertpapiers legt kräftig zu.…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…
Heres why DexCom should be on your radar after the companys share price plunged recently.…
Heres why DexCom should be on your radar after the companys share price plunged recently.…
DexCom (DXCM) announces that Quebec residents aged two years and older living with type 1 diabetes may now be eligible…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…
RADNOR, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
SAN FRANCISCO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered…
DexCom now trades at a drastically lower earnings multiple than it has in the past.…
…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…
Recently, weight loss and diabetes watch company DexCom Inc. (NASDAQ: DXCM) stock plummeted by over 44% on a surprisingly bad…
NEWTOWN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, is…
St. Petersburg (www.aktiencheck.de) - Rating-Update:
Raymond James bewertet die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…
St. Louis (www.aktiencheck.de) - Rating-Update:
Die Analysten von Stifel stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4,…
DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…
DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…
New York (www.aktiencheck.de) - Rating-Update:
Morgan Stanley stuft die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…
In einem bedeutenden Fortschritt für die Diabetesbehandlung wurde kürzlich eine neue Softwareintegration für Insulinpumpen zugelassen. Diese ermöglicht die Kompatibilität mit…
Zürich (www.aktiencheck.de) - Rating-Update:
Die Analysten der UBS stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol:…
These are the stocks posting the largest moves in midday trading.…
Die DexCom-Aktie verzeichnete einen deutlichen Rückgang, nachdem das Unternehmen seine Umsatzprognose für das Gesamtjahr 2024 nach unten korrigierte. Trotz eines…
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Today on Market Domination, hosts Josh Lipton and Julie Hyman delve into economic data, trending tickers, and investment strategies. The…
DexCom (DXCM), the maker of glucose monitoring systems for diabetics, is seeing a major decline in its stock price on…
DexCom (DXCM) stock plunged to a four-year low as Wall Street downgraded the company after its decision to slash the…
Toronto (www.aktiencheck.de) - DexCom-Aktienanalyse von RBC Capital Markets:
Die Analysten vom Investmenthaus RBC Capital Markets stufen die Aktie von DexCom Inc.…
These are the stocks posting the largest moves in midday trading.…
Dexcom, which had its stock market debut in 2005, is headed for its worst day ever after lowering its full-year…
Dexcom’s stock slid by about 40% following its second-quarter earnings report, after the diabetes sensor maker said it saw not…
DexCom Inc (NASDAQ:DXCM, ETR:DC4), a medical device maker that produces continuous glucose monitoring systems for diabetes management, shares plunged by...…
Zum Wochenende hin berappeln sich viele US-Aktien. Nach einer schwachen Woche zeigen vor allem US-Technologiewerte Erholungs-Tendenz. Der Nasdaq 100 nähert…
New York (www.aktiencheck.de) - DexCom-Aktienanalyse von Oppenheimer:
Steven Lichtman, Analyst von Oppenheimer, senkt in einer aktuellen Aktienanalyse das Kursziel für die…
DexCom (DXCM) stock plummets Friday morning — carrying into the market open — after missing second quarter revenue estimates and…
These are the stocks posting the largest moves in premarket trading.…
Bristol-Myers, 3M and Deckers rise premarket; Dexcom falls…
Kulmbach (www.aktiencheck.de) - DexCom-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Der amerikanische Spezialist für Glukose-Monitoring-Systeme hat am Donnerstag nach US-Börsenschluss für lange Gesichter gesorgt. Das Papier von DexCom bricht nach…
…
DXCM earnings call for the period ending June 30, 2024.…
…
DexComs (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth.…
Dexcom shares plunge after it cuts annual revenue forecast…
Dexcom issued disappointing results and guidance, which the company attributed in part to a change in its salesforce.…
After-hours movers: DexCom, Skechers, Deckers Brands, and more…
Dexcom cuts guidance as Q2 revenue falls short of estimates; shares slump…